A detailed history of Groupama Asset Managment transactions in Legend Biotech Corp stock. As of the latest transaction made, Groupama Asset Managment holds 22,782 shares of LEGN stock, worth $993,523. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,782
Previous 21,422 6.35%
Holding current value
$993,523
Previous $1.2 Billion 16.02%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $53,720 - $77,819
1,360 Added 6.35%
22,782 $1.01 Billion
Q1 2024

May 14, 2024

BUY
$55.06 - $69.99 $1.18 Million - $1.5 Million
21,422 New
21,422 $1.2 Billion

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.3B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.